These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 13755702)

  • 21. Clinical experiences with 5-fluorouracil.
    CALABRESI P; BRODY JI; PERILLIE PE; FINCH SC
    Conn Med; 1960 Jul; 24():415-21. PubMed ID: 13806845
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of far-advanced cancer with 5-fluorouracil, used alone and in combination with irradiation. Incidence and duration of remission and survival-time data in 223 patients.
    HALL BE; GOOD JW
    Cancer Chemother Rep; 1962 Feb; 16():369-86. PubMed ID: 13903837
    [No Abstract]   [Full Text] [Related]  

  • 23. Intra-arterial infusion of maligancies with 5-fluorouracil.
    TARR N; SENSENBRENNER LL; FLETCHER R; GRIFFING J
    Cancer Chemother Rep; 1961 Oct; 14():23-37. PubMed ID: 13919702
    [No Abstract]   [Full Text] [Related]  

  • 24. The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report.
    YOUNG CW; ELLISON RR; SULLIVAN RD; LEVICK SN; KAUFMAN R; MILLER E; WOLDOW I; ESCHER G; LI MC; KARNOFSKY DA; BURCHENAL JH
    Cancer Chemother Rep; 1960 Feb; 6():17-20. PubMed ID: 13846613
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors to be considered in the clinical evaluation of a new chemotherapeutic agent (5-fluorouracil).
    HYMAN GA; ULTMANN JE; HABIF DV
    Cancer Chemother Rep; 1962 Feb; 16():397-9. PubMed ID: 14450340
    [No Abstract]   [Full Text] [Related]  

  • 26. Five years clinical experience with 5-fluorouracil.
    ANSFIELD FJ; SCHROEDER JM; CURRERI AR
    JAMA; 1962 Jul; 181():295-9. PubMed ID: 13861733
    [No Abstract]   [Full Text] [Related]  

  • 27. Advanced neoplastic disease. Treatment with 5-fluorouracil and irradiation.
    HALL BE; GOOD JW
    Calif Med; 1961 Nov; 95(5):303-8. PubMed ID: 13903836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Problems in chemotherapy illustrated by the cytostatic 5-fluoruracil and the leukemias].
    OBRECHT P
    Strahlentherapie; 1961; Suppl 48():65-73. PubMed ID: 14481028
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on the feasibility of adjuvant chemotherapy with 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR) in the immediate postoperative period.
    JOHNSON RO; WOLBERG WH; CURRERI AR
    Arch Surg; 1962 Jul; 85():81-4. PubMed ID: 14452103
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study of 5-fluorouracil (FU), 5-fluorodeoxyuridine (FUDR), and methotrexate (MTX)-progress report.
    HALL TC
    Cancer Chemother Rep; 1962 Feb; 16():391-6. PubMed ID: 13903907
    [No Abstract]   [Full Text] [Related]  

  • 31. The potentiation of radiation effects with 5-fluorouracil.
    FOYE LV; WILLETT FM; HALL B; ROTH M
    Cancer Chemother Rep; 1960 Feb; 6():12-5. PubMed ID: 13824277
    [No Abstract]   [Full Text] [Related]  

  • 32. Objective remission of metastatic breast carcinoma in a male who recieved 17-alpha hydroxy progesterone caproate (delalutin).
    GELLER J; VOLK H; LEWIN M
    Cancer Chemother Rep; 1961 Oct; 14():77-81. PubMed ID: 13897631
    [No Abstract]   [Full Text] [Related]  

  • 33. Triethylene thiophosphoramide in the treatment of previously hypophysectomised patients with carcinoma of the breast.
    GURLING KJ
    Br J Cancer; 1959 Jun; 13(2):168-72. PubMed ID: 13830363
    [No Abstract]   [Full Text] [Related]  

  • 34. ThioTEPA in carcinoma of breast treated by bilateral adrenalectomy and oophorectomy.
    MILLER AB
    Br Med J; 1961 Mar; 1(5226):619-21. PubMed ID: 13770723
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma.
    Rivera E; Valero V; Cristofanilli M; Frye DK; Booser DJ; Rosales MM; Hortobagyi GN
    Cancer; 2002 May; 94(9):2321-6. PubMed ID: 12015755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclophosphamide therapy in carcinoma of the breast and ovary--a comparative study of intermittent massive vs. continuous maintenance dosage regimens.
    COGGINS PR; EISMAN SH; ELKINS WL; RAVDIN RG
    Cancer Chemother Rep; 1961 Dec; 15():3-8. PubMed ID: 13880179
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chemotherapy of carcinoma of the breast with triethylene thiophosphoramide].
    PERACCHIA A; FESANI F
    Tumori; 1960; 46():205-15. PubMed ID: 14431697
    [No Abstract]   [Full Text] [Related]  

  • 38. Carcinoma of the breast treated with thio-TEPA.
    HOLDEN H; SUNDSTRUP B
    Med J Aust; 1959 Nov; 46(2)():671-5. PubMed ID: 14402564
    [No Abstract]   [Full Text] [Related]  

  • 39. [Considerations on the use of Thiotepa Simes in metastatic tumoral diseases of mammary origin].
    BRACONNIER G
    Gazz Med Ital; 1961 Nov; 120():425-6. PubMed ID: 13872292
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of a breast cancer patient with Endoxan and an anabolic hormone. Empirical report].
    KILL JM
    Munch Med Wochenschr; 1961 Sep; 103():1767-8. PubMed ID: 13755948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.